Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
toldimfos sodium
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous, Subcutaneous
01
Overview
Toldimfos sodium (also commonly referred to as toldimphos sodium) is an aromatic organic phosphorus compound used in veterinary medicine as a metabolic stimulant and phosphorus supplement. Originally developed by Hoechst in the 1920s for human use to treat physical weakness and exhaustion, it is now exclusively utilized in veterinary medicine. It is indicated for livestock (such as cattle, sheep, goats, pigs, and horses) and companion animals (dogs and cats) to treat and prevent phosphorus deficiencies, general metabolic disorders, debility, and skeletal defects like rickets and osteomalacia. It is also highly effective in treating tetany and paresis caused by calcium, magnesium, and phosphorus metabolism disorders, such as post-parturient paresis (downer cow syndrome) in cattle. Formulated as an injectable solution, toldimfos sodium is rapidly absorbed and excreted unchanged in the urine, acting to stimulate metabolism and support cellular energy production without accumulating in tissues.
- Brand names
- FostonMetafosMetagenMetaphosolNovofosfanPhiniphosPhosodylTonofosfanTonophosTonophosphanTonotest
- Other names
- sodium (4-(dimethylamino)-2-methylphenyl)phosphinatesodium [4-(dimethylamino)-2-methylphenyl]phosphinatesodium [4-(dimethylamino)-2-methylphenyl]phosphinate trihydratetoldimfostoldimfos sodium trihydratetoldimphostoldimphos sodiumtoldimphos sodium trihydrate
Beyond the preview
Go deeper on toldimfos sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on toldimfos sodium.